Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTCH
2951
DELISTED
Latch, Inc. Common Stock
LTCH
| $3.78M | ﹤0.01% |
885,854
+35,539
| +4% | +$186K |
|
|
MCBC
2952
DELISTED
Macatawa Bank Corp
MCBC
| $3.77M | ﹤0.01% |
419,079
+16,560
| +4% | +$152K |
|
2953
Avita Medical
RCEL
$143M
| $3.77M | ﹤0.01% |
444,706
+22,786
| +5% | +$210K |
|
2954
American Superconductor
AMSC
$1.61B
| $3.76M | ﹤0.01% |
494,724
+29,079
| +6% | +$249K |
|
2955
Garrett Motion
GTX
$5.89B
| $3.76M | ﹤0.01% |
523,316
+25,528
| +5% | +$183K |
|
2956
Limoneira
LMNR
$251M
| $3.74M | ﹤0.01% |
254,841
+6,699
| +3% | +$97.4K |
|
2957
Quantum-Si Incorporated
QSI
$168M
| $3.73M | ﹤0.01% |
797,207
+30,297
| +4% | +$148K |
|
|
KLRS
2958
Kalaris Therapeutics
KLRS
$102M
| $3.71M | ﹤0.01% |
23,914
+516
| +2% | +$103K |
|
2959
Global E Online
GLBE
$6.86B
| $3.69M | ﹤0.01% |
109,347
+560
| +0.5% | +$21.1K |
|
|
NUVL
2960
DELISTED
Nuvalent
NUVL
| $3.69M | ﹤0.01% |
265,908
+92,504
| +53% | +$1.34M |
|
2961
Viridian Therapeutics
VRDN
$2.41B
| $3.68M | ﹤0.01% |
199,238
-2,440
| -1% | -$46.9K |
|
|
CINC
2962
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $3.66M | ﹤0.01% |
+208,898
| New | +$4.29M |
|
2963
Nature's Sunshine
NATR
$349M
| $3.66M | ﹤0.01% |
217,481
+5,952
| +3% | +$105K |
|
2964
Precigen
PGEN
$2.5B
| $3.65M | ﹤0.01% |
1,728,560
-29,112
| -2% | -$70.9K |
|
2965
Capital Bancorp
CBNK
$613M
| $3.65M | ﹤0.01% |
159,465
+6,668
| +4% | +$163K |
|
|
DOO
2966
Bombardier Recreational Products
DOO
$4.77B
| $3.63M | ﹤0.01% |
44,386
+253
| +0.6% | +$19.2K |
|
|
CTIC
2967
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.63M | ﹤0.01% |
777,616
+94,990
| +14% | +$283K |
|
2968
CorMedix
CRMD
$580M
| $3.62M | ﹤0.01% |
661,397
+17,939
| +3% | +$82.1K |
|
2969
Donegal Group Class A
DGICA
$731M
| $3.6M | ﹤0.01% |
268,130
+6,171
| +2% | +$86.2K |
|
|
JBIO
2970
Jade Biosciences
JBIO
$1.36B
| $3.58M | ﹤0.01% |
5,577
+1,070
| +24% | +$415K |
|
|
VLDR
2971
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $3.57M | ﹤0.01% |
1,394,332
-271,898
| -16% | -$930K |
|
|
GRTS
2972
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.56M | ﹤0.01% |
863,550
-4,178
| -0.5% | -$22.1K |
|
|
GAN
2973
DELISTED
GAN Ltd
GAN
| $3.55M | ﹤0.01% |
736,804
+18,134
| +3% | +$117K |
|
2974
Sight Sciences
SGHT
$377M
| $3.54M | ﹤0.01% |
305,816
+112,794
| +58% | +$1.74M |
|
|
NXDR
2975
Nextdoor Holdings
NXDR
$959M
| $3.53M | ﹤0.01% |
589,400
+17,039
| +3% | +$104K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,081 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.